G2082 Visit esketamine 56m or less

Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 1 units per day (practitioner), rationale: Code Descriptor / CPT Instruction